Midbrain from mice aged 6 months were extracted with Trizol (Invitrogen) following manufacturer’s instructions. Before cDNA synthesis, 1 μg of RNA was digested with DNase I Amplification Grade (Invitrogen). Reverse transcription was performed with SuperScript III Reverse Transcriptase (Invitrogen). Subsequently, expression levels were measured with the StepOnePlus Real-Time PCR System (Applied Biosystems) using cDNA from 25 ng RNA, 10 μl of FastStart Universal Probe Master (Rox) Mix (04914058001, Roche) and 1 μl of one of the following TaqMan Assays (Applied Biosystems): Adora2b (Mm00839292_m1), Dapk1 (Mm01352536_m1), Dcaf17 (Mm01334341_m1), Dctn5 (Mm00727515_s1), Homer1 (Mm00516275_m1), Mrpl9 (Mm00659648_m1), Mrpl9 (Mm00659648_m1), Pink1 (Mm00550827_m1) as independent control of genotypes, Rab42 (Mm01187370_g1), Tmem181a (Mm02581460_g1), Xaf1 (Mm01248390_m1), Lect1 (Mm00495291_m1) and Tbp (Mm00446973_m1) as endogenous control. Expression changes were analyzed both with the 2−ΔΔCt method, as previously described (77 (link)).